Hans Roland Dürr

Hans Roland Durr is a German orthopedic oncologist specializing in limb-sparing surgery for primary bone tumors and surgical reconstruction following tumor resection. He has extensive experience in endoprosthetic reconstruction of the extremities after osteosarcoma, Ewing sarcoma, and giant cell tumor resection. Durr has contributed clinical data supporting denosumab as a medical treatment for giant cell tumor of bone, enabling conversion of unresectable lesions to surgically resectable state. His surgical volume and outcomes research has contributed to quality benchmarks in bone tumor surgery in the European context.